Physician profile
Sumana Jothi
NPI 1609931484
$4,790.80
in general payments reported to CMS, 2019-2025
11 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,897 · 2020: $217 · 2021: $181 · 2022: $1,656 · 2023: $99.41 · 2024: $438 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,089.07 | 2019-2023 | Coblation, Stravix |
| Aerin Medical INC. | $1,590.47 | 2021-2022 | |
| Inspire Medical Systems, INC. | $413.95 | 2024-2025 | Inspire |
| Olympus America INC. | $229.71 | 2024-2025 | Olympus, Rhino-Laryngo Fiberscope, Diego Elite |
| Intersect Ent, INC. | $179.81 | 2020-2021 | |
| Stryker Corporation | $104.60 | 2020-2022 | |
| Abbott Laboratories | $71.90 | 2024-2025 | Esprit |
| Osiris Therapeutics INC. | $46.49 | 2019 | |
| Merz North America, INC. | $26.54 | 2019 | |
| Bard Peripheral Vascular, INC. | $24.86 | 2025 | Rotarexs 6 F X 135 Cm |
| Pacira Pharmaceuticals Incorporated | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumana Jothi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.